30-Second Coronavirus Test Returns Results as Accurately and Sensitively as PCR Test

With any highly infectious disease, time can be a killer. It is crucial to get a test result for a pathogen quickly, lest someone continue in their daily lives infecting others. And delays in testing have undoubtedly exacerbated the COVID-19 pandemic. Unfortunately, the most accurate COVID-19 test often takes 24 hours or longer to return results from a lab. At-home test kits offer results in minutes but are far less accurate or sensitive. Researchers have now developed a COVID-19 testing device that can detect coronavirus infection in as little as 30 seconds as sensitively and accurately as a PCR, or polymerase chain reaction test, the gold standard of testing.

Researchers at the University of Florida (Gainesville, FL, USA) in association with scientists at National Yang Ming Chiao Tung University (Taipei, Taiwan) have developed the device that could transform public health officials’ ability to quickly detect and respond to the coronavirus - or the next pandemic. Like PCR tests, the device is 90% accurate with the same sensitivity, according to a recent peer-reviewed study.

The hand-held apparatus is powered by a 9-volt battery and uses an inexpensive test strip, similar to those used in blood glucose meters, with coronavirus antibodies attached to a gold-plated film at its tip. The strip is placed on the tongue to collect a tiny saliva sample. The strip is then inserted into a reader connected to a circuit board with the brains of the device. If someone is infected, the coronavirus in the saliva binds with the antibodies and begins a dance of sorts as they are prodded by two electrical pulses processed by a special transistor. A higher concentration of coronavirus changes the electrical conductance of the sample. That, in turn, alters the voltage of the electrical pulses.

The voltage signal is amplified a million times and converted to a numerical value - in a sense, the sample’s electrochemical fingerprint. That value will indicate a positive or negative result, and the lower the value, the higher the viral load. The device’s ability to quantify viral and antibody load makes it especially useful for clinical purposes, according to the researchers. The product can be constructed for less than USD 50 in contrast to PCR test equipment which can cost thousands.

Several institutions have worked on devices using a field effect transistor, or FET, like that found in the COVID-19 testing device which the researchers are developing. But those devices are basically one-offs - a sample is applied directly to the FET, which means the transistor is not reusable and must be discarded. That makes those devices expensive and impractical for mass testing. Then the researchers hit upon on the idea of separating the transistor from the sample, like blood glucose meters that use test strips to collect a drop of blood after a lancet pierces a finger. This innovation makes the device unique, affordable and easy to use. The device could be used for venues with large crowds, such as concerts, sporting events, classrooms, in addition to medical settings. The unit would also provide access to accurate, inexpensive testing in rural areas or in developing nations and offers limitless options for personal uses.

The device is not yet approved by the U.S. Food and Drug Administration. First, the researchers will have to ensure that test results are not thrown off by cross-contamination with other pathogens that might be found in the mouth and saliva. These include other coronaviruses, staph infections, the flu, pneumonia and 20 others. The research team is also studying its ability to detect specific proteins that could be used to diagnose other illnesses, including cancer, a heart attack and immune health.

“There is nothing available like it,” said Josephine Esquivel-Upshaw, D.M.D., a professor in the UF College of Dentistry’s department of restorative dental sciences and member of the research team that developed the device. “It’s true point of care. It’s access to care. We think it will revolutionize diagnostics.”

Related Links:
University of Florida
National Yang Ming Chiao Tung University 

Visit expo >

Gold Member

SARS-CoV-2 Reactive & Non-Reactive Controls

Qnostics SARS-CoV-2 Typing

Antipsychotic TDM AssaysSaladax Antipsychotic Assays

New

Anti-Secukinumab ELISA

LISA-TRACKER anti-Secukinumab

New

Thyroxine ELISA

T4 ELISA